Endocrine Disrupting Chemicals and Reproductive Health in Boys and Men

dc.contributor.authorRodprasert Wiwat
dc.contributor.authorToppari Jorma
dc.contributor.authorVirtanen Helena E.
dc.contributor.organizationfi=biolääketieteen laitos|en=Institute of Biomedicine|
dc.contributor.organizationfi=tyks, vsshp|en=tyks, varha|
dc.contributor.organization-code1.2.246.10.2458963.20.77952289591
dc.converis.publication-id67339629
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/67339629
dc.date.accessioned2022-10-27T11:51:25Z
dc.date.available2022-10-27T11:51:25Z
dc.description.abstract<p>le reproductive health has declined as indicated by increasing rates of cryptorchidism, i.e., undescended testis, poor semen quality, low serum testosterone level, and testicular cancer. Exposure to endocrine disrupting chemicals (EDCs) has been proposed to have a role in this finding. In utero exposure to antiandrogenic EDCs, particularly at a sensitive period of fetal testicular development, the so-called ‘masculinization programming window (MPW)’, can disturb testicular development and function. Low androgen effect during the MPW can cause both short- and long-term reproductive disorders. A concurrent exposure to EDCs may also affect testicular function or damage testicular cells. Evidence from animal studies supports the role of endocrine disrupting chemicals in development of male reproductive disorders. However, evidence from epidemiological studies is relatively mixed. In this article, we review the current literature that evaluated relationship between prenatal EDC exposures and anogenital distance, cryptorchidism, and congenital penile abnormality called hypospadias. We review also studies on the association between early life and postnatal EDC exposure and semen quality, hypothalamic-pituitary-gonadal axis hormone levels and testicular cancer.<br><br></p>
dc.identifier.eissn1664-2392
dc.identifier.jour-issn1664-2392
dc.identifier.olddbid172323
dc.identifier.oldhandle10024/155417
dc.identifier.urihttps://www.utupub.fi/handle/11111/30021
dc.identifier.urnURN:NBN:fi-fe2021100750203
dc.language.isoen
dc.okm.affiliatedauthorRodprasert, Wiwat
dc.okm.affiliatedauthorToppari, Jorma
dc.okm.affiliatedauthorDataimport, tyks, vsshp
dc.okm.affiliatedauthorVirtanen, Helena
dc.okm.discipline3111 Biomedicineen_GB
dc.okm.discipline3111 Biolääketieteetfi_FI
dc.okm.internationalcopublicationnot an international co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA2 Scientific Article
dc.publisherFRONTIERS MEDIA SA
dc.publisher.countrySwitzerlanden_GB
dc.publisher.countrySveitsifi_FI
dc.publisher.country-codeCH
dc.relation.doi10.3389/fendo.2021.706532
dc.relation.ispartofjournalFrontiers in Endocrinology
dc.relation.volume12
dc.source.identifierhttps://www.utupub.fi/handle/10024/155417
dc.titleEndocrine Disrupting Chemicals and Reproductive Health in Boys and Men
dc.year.issued2021

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
fendo-12-706532.pdf
Size:
2.71 MB
Format:
Adobe Portable Document Format
Description:
Publisher's PDF (CC BY)